Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Ernst-Rüdiger Kuse, Ploenchan Chetchotisakd(Khon Kaen University), Clóvis Arns da Cunha, Markus Ruhnke(Charité - Universitätsmedizin Berlin), Carlos H. Barrios(Hospital São Lucas da PUCRS), Digumarti Raghunadharao(Nizam's Institute of Medical Sciences), Jagdev Singh Sekhon(Dayanand Medical College & Hospital), Antonio Freire(Grupo Santa Casa de Belo Horizonte), V Ramasubramanian(Apollo Hospitals), Ignace Demeyer(Onze Lieve Vrouwziekenhuis Hospital), Márcio Nucci(Hospital Universitário Clementino Fraga Filho), Amorn Leelarasamee(Siriraj Hospital), Frédérique Jacobs(Erasmus Hospital), Johan Decruyenaere(Ghent University Hospital), Didier Pittet(University of Geneva), Andrew J. Ullmann(Johannes Gutenberg University Mainz), Luis Ostrosky‐Zeichner, Olivier Lortholary(Hôpital Necker-Enfants Malades), Sonja Koblinger(Astellas Pharma (Japan)), Heike Diekmann-Berndt(Astellas Pharma (Japan)), Oliver A. Cornely(Centrum für Integrierte Onkologie)
The Lancet
April 27, 2007
Cited by 689

Abstract


Related Papers

No related papers found

Powered by citation graph analysis